For NFKB1-94 ins/del polymorphism, a significantly decreased prostate cancer risk was observed in the heterozygous comparison model (ins/del versus ins/ins) and homozygous comparison model (del/del versus ins/ins). This evidence concerns the gene NFKB1 and Familial prostate cancer.